Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Loxo Oncology Company Profile (NASDAQ:LOXO)

Consensus Ratings for Loxo Oncology (NASDAQ:LOXO) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $20.75 (90.54% upside)

Analysts' Ratings History for Loxo Oncology (NASDAQ:LOXO)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/2/2014Leerink SwannInitiated CoverageOutperform$20.00ViewTweet This Rating  Share This Rating on StockTwits
9/2/2014OppenheimerInitiated CoverageOutperform$20.00ViewTweet This Rating  Share This Rating on StockTwits
9/2/2014Cowen and CompanyInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
9/2/2014Stifel NicolausInitiated CoverageBuy$20.00ViewTweet This Rating  Share This Rating on StockTwits
8/26/2014JMP SecuritiesInitiated CoverageOutperform$23.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/24/2012 forward)
Discuss Loxo Oncology